Ken d’Entremont

Ken d’Entremont

Chief Executive Officer and Director

Ken d’Entremont is the founder, president, and CEO of Medexus Inc. Previously, he was the general manager and vice president of business development at Sanofi, where he led the in-licensing initiatives for Sanofi Canada. Mr. d’Entremont holds a Bachelor of Science in Chemistry from McMaster University.

Roland Boivin

Roland Boivin

Chief Financial Officer

Roland Boivin was appointed as CFO of Pediapharm on July 1, 2013. He has held several management positions at 3M Canada, was a member of the company’s executive leadership team, and had overall responsibility of the consumer division. Mr. Boivin holds a Bachelor of Commerce from McGill, a Master of Business Administration from Queen's University, and is a certified Six Sigma Black Belt.

Michael Adelman

Michael Adelman

General Manager, U.S. Operations

Michael Adelman joined Medexus in 2020 from Aptevo Therapeutics, where he led all commercial functions as SVP, Commercial Operations.  Mr. Adelman has over 25 years of life-science commercial experience, including leadership roles at Emergent BioSolutions, Cangene, Adolor, and AstraZeneca.  Mr. Adelman holds a Bachelor of Science in Finance from Northeastern University and Master of Business Administration from New York University’s Stern School of Business.

Michael Pine

Michael Pine

Senior Vice President of Business Development and Strategy

Michael Pine joined Medexus in 2020 from Lupin Pharmaceuticals, where he served as SVP BD&L, responsible for expanding further into branded specialty products. Mr. Pine has over 20 years of experience as a pharmaceutical industry executive and business leader with a diverse background in both large and small pharmaceutical companies that includes functions in: business development & licensing, M&A, investment banking, strategy, marketing, US managed markets, and operations. Prior positions include senior roles at companies such as Aralez, Novartis, Kos Pharmaceuticals, Organon, Pfizer, and JP Morgan Chase. Mr. Pine has a BS in Consumer Economics from Cornell University and an MBA from Columbia Business School.

Richard Labelle

Richard Labelle

Vice President Allergy, Pediatric and OTC Portfolios, Canadian Operations

Richard Labelle joined Medexus (Pediapharm legacy) in February of 2014.  Previously he was the general manager and vice president of the consumer portfolio at Sanofi. He has held several management positions including heading commercial operations for the cardiovascular and osteoporosis divisions. He also led the business development team at Aventis. Mr. Labelle holds a Bachelor of Commerce from University of Quebec and a Master of Business Administration from McGill – HEC executive program.